MUMBAI, June 8 (Reuters) – India’s largest drugmaker Sun
Pharmaceutical Industries expects its domestic consumer
healthcare business to grow by up to 25 percent this year, led
by a renewed marketing…
The post RPT-UPDATE 1-India’s Sun Pharma aims for 25 pct growth in consumer health business appeared first on NASDAQ.